CRAIG A. TOOMAN

Insider Reports History

Location
London, United Kingdom
Signature
/s/ Rhonda Hellums, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by CRAIG A. TOOMAN:

Company Role Class Num Shares Value Price $ Report Date Ownership
Silence Therapeutics plc President and CEO, Director Employee Share Option (Right to Buy) 900,000 02 Jan 2025 Direct
Silence Therapeutics plc President and CEO, Director Ordinary Shares 33,486 02 Jan 2025 Direct

Insider Reports Filed by CRAIG A. TOOMAN

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SLN Silence Therapeutics plc 02 Jan 2025 1 $0 4 President and CEO, Director 06 Jan 2025, 16:15
SLN Silence Therapeutics plc 02 Jan 2025 0 $0 3 President and CEO, Director 02 Jan 2025, 16:39